Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.
This quarter, Werewolf Therapeutics experienced an increase in earnings per share, which was $-0.56 in Q1 and is now $-0.53. Most recently, Fonar reported earnings per share at $0.32, whereas in Q2 earnings per share sat at $0.57. ITeos Therapeutics saw a decrease in earnings per share from 1.82 in Q1 to $0.15 now. Assertio Holdings saw a decrease in earnings per share from 0.38 in Q1 to $0.28 now. QuidelOrtho saw a decrease in earnings per share from 11.66 in Q1 to $2.34 now.
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.